Milbeguard Duo 25 mg / 250 mg chewable tablets for large dogs

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Werkstoffen:

Milbemycin oxime; Praziquantel

Beschikbaar vanaf:

Ceva Santé Animale

ATC-code:

QP54AB51

INN (Algemene Internationale Benaming):

Milbemycin oxime; Praziquantel

farmaceutische vorm:

Chewable tablet

Prescription-type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutisch gebied:

milbemycin oxime, combinations

Autorisatie datum:

2024-01-19

Productkenmerken

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Milbeguard Duo 25 mg / 250 mg chewable tablets for large dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Milbemycin oxime
25 mg
Praziquantel
250 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
Povidone
Croscarmellose sodium
Lactose monohydrate
Chicken flavour*
Yeast
Cellulose microcrystalline
Silica, colloidal anhydrous
Magnesium stearate
_*Artificial origin _
Round tablet, beige to light brown, scored on one side. The tablet can
be divided into two equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs weighing at least 5 kg
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
In dogs: treatment of mixed infections by adult cestodes and nematodes
of the following species:
- Cestodes:
_Dipylidium caninum _
_Taenia _
spp
_. _
_Echinococcus _
spp
_. _
_Mesocestoides _
spp
_. _
- Nematodes:
_Ancylostoma caninum _
_Toxocara canis _
_Toxascaris leonina _
_Trichuris vulpis _
_Crenosoma vulpis_
(Reduction of the level of infection)
2
_Angiostrongylus vasorum _
(Reduction of the level of infection by immature adult (L5) and adult
parasite
stages; see specific treatment and prevention disease schedules under
section 3.9 “Administration routes
and dosage”)
_Thelazia callipaeda _
(see specific treatment schedule under section 3.9 “Administration
routes and
dosage”)
The product can also be used in the prevention of heartworm disease (
_Dirofilaria immitis_
) if
concomitant treatment against cestodes is indicated.
3.3
CONTRAINDICATIONS
Do not use in dogs weighing less than 5 kg.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
See also section 3.5 "Special precautions for use".
3.4
SPECIAL WARNINGS
It is recommended to treat all the animals living in the same
household concomitantly. When infection
with the cestode
_D. caninum _
has been confirmed, concomitant treatment against intermediate hosts,
such
as fleas and lice, should be discussed with a veterinaria